RYR2 deficient human model identifies calcium handling and metabolic dysfunction impacting pharmacological responsesLinda M. Starnes(AstraZeneca (Sweden)), Amy Pointon(Medical Research Council)Frontiers in Cardiovascular MedicineJuly 8, 202410.3389/fcvm.2024.1357315Cited by 4SaveCiteExport RISWatch citationsRelated PapersDoxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation|PLoS ONE|2010|127